Cerebrospinal Fluid Pleocytosis following Meningococcal B vaccination in an Infant


Authors: Oligbu Godwin
Authors‘ workplace: Paediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St. George's, University of London, UK
Published in: Epidemiol. Mikrobiol. Imunol. 67, 2018, č. 4, s. 0
Category: Short Communication

Overview

We describe a case of cerebrospinal fluid pleocytosis in a previously well infant after his first immunisation with the multicomponent meningococcal serogroup B and advice clinicians to be cautious with the interpretation of CSF findings in children post Meningococcal B vaccination until clearer guidelines are available

Keywords:

meningococcal B vaccine – cerebrospinal fluid pleocytosis – inflammatory response – infant


Sources

1. Department of Health Immunisation against infectious disease - “The Green Book”. 2016. Dostupné na www: http://immunisation.dh.gov.uk/category/the-green-book/.

2. Parikh SR, Andrews NJ, Beebeejaun K, et al. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet, 2016;388:2775–2782.

3. Nainani V, Galal U, Buttery J, Snape MD. An increase in accident and emergency presentations for adverse events following immunisation after introduction of the group B meningococcal vaccine: an observational study. Arch Dis Child, 2017;102:958–962.

4. Kapur S, Bourke T, Maney JA, Moriarty P. Emergency department attendance following 4-component meningococcal B vaccination in infants. Arch Dis Child, 2017. doi: 10.1136/archdischild-2016-311020.

5. Gossger N, Snape MD, Yu LM, Finn A, Bona G, Esposito S, et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. 2012;307:573–582.

6. Martin NG, Snape MD. A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn? Expert Rev Vaccines. 2013;12:837–858.

7. Prymula R, Esposito S, Zuccotti GV, Xie F, Toneatto D, Kohl I, Dull PM. A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I). Hum Vaccin Immunother, 2014;10:1993–2004.

8. National Health Service (NHS). Using paracetamol to prevent and treat fever after MenB vaccination. Dostupné na www: <https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/483408/9413-paracetamol-menB-2page-A4-08-web.pdf> [accessed 02.05.18].

9. Harcourt S, Morbey RA, Bates C, Carter H, Ladhani SN, de Lusignan S, et al. Estimating primary care attendance rates for fever in infants after meningococcal B vaccination in England using national syndromic surveillance data. Vaccine, 2018;36(4):565–571.

10. Rossi LN, Sella FV, Bajc O, Tönz O, Lütschg J, Mumenthaler M. Benign migraine-like syndrome with csf pleocytosis in children. Dev Med Child Neurol, 1985;27(2):192–198.

11. Edwards R, Schmidley JW, Simon RP. How often does a CSF pleocytosis follow generalized convulsions? Ann Neurol, 1983;13(4):460–462.

12. Saito H, Yanagisawa T. Acute cerebellar ataxia after influenza vaccination with recurrence and marked cerebellar atrophy. The Tohoku journal of experimental medicine, 1989;158(1):95–103.

13. Naruse H, Miwata H, Ozaki T, Asano Y, Namazue J, Yamanishi K. Varicella infection complicated with meningitis after immunization. Pediatrics International, 1993;35(4):345–347.

14. National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management. NICE 2013. Dostupné na www: https://www.nice.org.uk/guidance/cg160 (cited 5 May 2018).

Labels
Hygiene and epidemiology Medical virology Clinical microbiology
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account